Association of HLA-DRB1-restricted CD4+ T cell responses with HIV immune control

Nature Medicine

Volumn 19, Issue 7, 2013, Pages 930-933

  Ranasinghe, Srinika ^a   Cutler, Sam ^a   Davis, Isaiah ^a   Lu, Richard ^a,f   Soghoian, Damien Z ^a   Qi, Ying ^b   Sidney, John ^c   Kranias, Gregory ^a,f   Flanders, Michael D ^a   Lindqvist, Madelene ^a   Kuhl, Bjorn ^a   Alter, Galit ^a   Deeks, Steven G ^d   Walker, Bruce D ^a,e   Gao, Xiaojiang ^b   Sette, Alessandro ^c   Carrington, Mary ^a,b   Streeck, Hendrik ^a,f  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b SAIC FREDERICK INC   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^f HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DRB1 ANTIGEN;

ALLELE; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; PRIORITY JOURNAL; VIREMIA;

ALLELES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COHORT STUDIES; DISEASE RESISTANCE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HIV INFECTIONS; HIV-1; HLA-DRB1 CHAINS; HUMANS; VIRAL LOAD; VIRUS REPLICATION;

EID: 84880286540     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3229     Document Type: Article

References (21)

1. Aubert, R.D. et al. Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection. Proc. Natl. Acad. Sci. USA 108, 21182-21187 (2011).
2. Wilkinson, T.M. et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat. Med. 18, 274-280 (2012).
3. Soghoian, D.Z. et al. HIV-specific cytolytic CD4 T cell responses during acute HIV-1 infection predict disease outcome. Sci. Transl. Med. 4, 123ra25 (2012).
4. Whitmire, J.K. Induction and function of virus-specific CD4+ T cell responses. Virology 411, 216-228 (2011).
5. Soghoian, D.Z. & Streeck, H. Cytolytic CD4+ T cells in viral immunity. Expert Rev. Vaccines 9, 1453-1463 (2010).
6. Streeck, H., D'Souza, M.P., Littman, D.R. & Crotty, S. Harnessing CD4+ T cell responses in HIV vaccine development. Nat. Med. 19, 143-149 (2013).
7. Douek, D.C. et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 417, 95-98 (2002).
8. Ranasinghe, S. et al. HIV-specific CD4 T cell responses to different viral proteins have discordant associations with viral load and clinical outcome. J. Virol. 86, 277-283 (2012).
9. Carrington, M. & Walker, B.D. Immunogenetics of spontaneous control of HIV. Annu. Rev. Med. 63, 131-145 (2012).
10. International HIV Controller Study. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330, 1551-1557 (2010).
11. Apps, R. et al. Influence of HLA-C expression level on HIV control. Science 340, 87-91 (2013).
12. Malhotra, U. et al. Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment. J. Clin. Invest. 107, 505-517 (2001).
13. Julg, B. et al. Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection. J. Infect. Dis. 203, 803-809 (2011).
14. Southwood, S. et al. Several common HLA-DR types share largely overlapping peptide binding repertoires. J. Immunol. 160, 3363-3373 (1998).
15. Gerlach, J.T. et al. Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins. J. Virol. 79, 12425-12433 (2005).
16. Schulze zur Wiesch, J. et al. Broad repertoire of the CD4+ TH cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J. Immunol. 175, 3603-3613 (2005).
17. Gao, X. et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N. Engl. J. Med. 344, 1668-1675 (2001).
18. Trachtenberg, E. et al. Advantage of rare HLA supertype in HIV disease progression. Nat. Med. 9, 928-935 (2003).
19. Mallone, R. et al. Functional avidity directs T-cell fate in autoreactive CD4+ T cells. Blood 106, 2798-2805 (2005).
20. Caserta, S. et al. Reduced functional avidity promotes central and effector memory CD4 T cell responses to tumor-associated antigens. J. Immunol. 185, 6545-6554 (2010).
21. Streeck, H., Frahm, N. & Walker, B.D. The role of IFN-Elispot assay in HIV vaccine research. Nat. Protoc. 4, 461-469 (2009).